Patents Assigned to State University
  • Patent number: 9119842
    Abstract: Methods and materials for treating various diseases and medical conditions with meso-biliverdin compositions. In addition methods and materials for producing meso-biliverdin are provided where the methods include reacting phycocyanobilin with an amphoteric compound in a solvent to yield meso-biliverdin are provided.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: September 1, 2015
    Assignee: Utah State University
    Inventors: Jon Y. Takemoto, Dong Chen, Cheng-Wei T. Chang, Jonathan Wood
  • Patent number: 9124136
    Abstract: The present invention provides for the integration of distributed renewable energy sources/storages utilizing a cascaded DC-AC inverter, thereby eliminating the need for a DC-DC converter. The ability to segment the energy sources and energy storages improves the maintenance capability and system reliability of the distributed generation system, as well as achieve wide range reactive power compensation. In the absence of a DC-DC converter, single stage energy conversion can be achieved to enhance energy conversion efficiency.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: September 1, 2015
    Assignee: The Florida State University Research Foundation, Inc.
    Inventors: Liming Liu, Hui Li
  • Patent number: 9123985
    Abstract: A training module, training system, and methods of monitoring physical activity and making a training module are disclosed. The training module includes a compressible article having a polyhedral outer surface, a motion detector that detects compressive and rotational movement of the compressible article, a controller that determines a number of compressions and a number of rotations of the compressible article, and a signal transmitter that transmits data to a mobile electronic device. The controller is in electrical communication with the motion detector and the signal transmitter. The training system and methods generally include those that embody one or more of the inventive concepts disclosed herein.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 1, 2015
    Assignees: California State University, Fresno
    Inventors: Brian Zwaschka, Barry Velasquez
  • Patent number: 9122873
    Abstract: Trustworthy systems require that code be validated as genuine. Most systems implement this requirement prior to execution by matching a cryptographic hash of the binary file against a reference hash value, leaving the code vulnerable to run time compromises, such as code injection, return and jump-oriented programming, and illegal linking of the code to compromised library functions. The Run-time Execution Validator (REV) validates, as the program executes, the control flow path and instructions executed along the control flow path. REV uses a signature cache integrated into the processor pipeline to perform live validation of executions, at basic block boundaries, and ensures that changes to the program state are not made by the instructions within a basic block until the control flow path into the basic block and the instructions within the basic block are both validated.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: September 1, 2015
    Assignee: The Research Foundation for the State University of New York
    Inventor: Kanad Ghose
  • Patent number: 9120858
    Abstract: The present invention provides anti-TCblR antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of cancer, tumors and other proliferative diseases and disorders.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: September 1, 2015
    Assignee: The Research Foundation of State University of New York
    Inventors: Edward V. Quadros, Jeffrey M. Sequeira
  • Patent number: 9125288
    Abstract: For ion-mode plasma containment, a toroidal vacuum vessel (322) has a major radius (208) and a minor radius (212). The toroidal vacuum vessel (322) is filled with a gas (391) having an initial particle density. An ionizing device (341) ionizes the gas (391) into a plasma (400). A transformer inductively (326) drives a toroidal particle current (332) comprising an ion current and an electron current about a toroidal axis. The toroidal particle current (322) heats the plasma (400) and generates a poloidal magnetic field (373). Field coils (414) wound poloidally about the toroidal vacuum vessel (322) generate a toroidal magnetic field (371). The toroidal magnetic field (371) at a wall of the toroidal vacuum vessel (322) is adjusted to satisfy a boundary condition for a minimum-energy. The plasma (400) is contained by the radial electric field, the poloidal magnetic field (373), and the toroidal magnetic field (371) within the toroidal vacuum vessel (322) in the minimum-energy state.
    Type: Grant
    Filed: November 8, 2011
    Date of Patent: September 1, 2015
    Assignee: Utah State University
    Inventors: W. Farrell Edwards, Eric D. Held, Ajay K. Singh
  • Patent number: 9120861
    Abstract: The present invention provides methods for adding functional hydrophobic, charge, polar, and other structural groups on antimicrobial compounds for enhancing the physicochemical properties of the antimicrobial compounds, thereby creating novel antimicrobial analogs with enhanced functions.
    Type: Grant
    Filed: October 16, 2009
    Date of Patent: September 1, 2015
    Assignee: Mississippi State University
    Inventor: James Leif Smith
  • Patent number: 9119810
    Abstract: Novel models of interactions of the Nonstructural Protein of influenza A and influenza B viruses (NS1A and NS1B, respectively) with dsRNA are presented. On the basis of the models, novel recombinant viruses and vaccines against influenza A and influenza B viruses are provided.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: September 1, 2015
    Assignees: Rutgers, The State University of New Jersey
    Inventors: Gaetano T. Montelione, Robert M. Krug, Yin Cuifeng, Ma Lichung
  • Patent number: 9123467
    Abstract: An apparatus for switch wear leveling includes a switching module that controls switching for two or more pairs of switches in a switching power converter. The switching module controls switches based on a duty cycle control technique and closes and opens each switch in a switching sequence. The pairs of switches connect to a positive and negative terminal of a DC voltage source. For a first switching sequence a first switch of a pair of switches has a higher switching power loss than a second switch of the pair of switches. The apparatus includes a switch rotation module that changes the switching sequence of the two or more pairs of switches from the first switching sequence to a second switching sequence. The second switch of a pair of switches has a higher switching power loss than the first switch of the pair of switches during the second switching sequence.
    Type: Grant
    Filed: January 23, 2013
    Date of Patent: September 1, 2015
    Assignee: Utah State University
    Inventors: Hunter Wu, Kylee Sealy, Aaron Gilchrist
  • Publication number: 20150238590
    Abstract: Salmonella enteric serotype Typhimurium is a causative agent for gastroenteritis. It is the leading cause of hospitalization and death caused by a food-borne pathogen in the US. As is the case with many gram- negative pathogens, Salmonella spp. use type III secretion systems (T3SS) to deliver proteins to host cells to induce infections. The T3SS uses a molecular syringe and needle, the type III secretion apparatus (T3SA), as a conduit for the transport of the T3SS proteins from the bacteria to the host. Because proteins associated with the tip of the T3SA are extracellular, they are potential protective subunit vaccine candidates against Salmonella. These pathogens also have a T3SS that is involved with intracellular escape from the vacuole with an associated T3SA. Within this invention, we begin to show proof of concept that these proteins are protective.
    Type: Application
    Filed: October 22, 2013
    Publication date: August 27, 2015
    Applicant: The Board of Regents for Oklahoma State University
    Inventors: Wendy L. Picking, William D. Picking
  • Publication number: 20150239748
    Abstract: The invention relates to nanomaterials and assemblies including, a micrometer-scale spherical aggregate comprising: a plurality of one-dimensional nanostructures comprising titanium and oxygen, wherein the one-dimensional nanostructures radiate from a hollow central core thereby forming a spherical aggregate.
    Type: Application
    Filed: April 29, 2013
    Publication date: August 27, 2015
    Applicant: The Research Foundation for The State University of New York
    Inventors: Stanislaus S. Wong, Yuanbing Mao
  • Publication number: 20150238140
    Abstract: A system for non-invasively monitoring a stress level of a subject is presented. A sensor is configured to monitor an attribute of the subject. A housing is configured to removably attach to the subject, the housing includes a processor in communication with the sensor, the processor is configured to retrieve data from the sensor, and use the data retrieved from the sensor to determine a stress level of the subject.
    Type: Application
    Filed: July 31, 2013
    Publication date: August 27, 2015
    Applicant: Arizona Board of Regents on behalf of Arizona State University
    Inventors: Jeffrey T. LaBelle, Jorge Tenorio, Kevin Uchimura, Benjamin Cantrill
  • Patent number: 9117636
    Abstract: A plasma device is disclosed. The plasma device includes: at least one electrode including a nanoporous dielectric layer disposed on at least a portion thereof, the nanoporous dielectric layer including a plurality of pores, wherein at least a portion of the plurality of pores include a catalyst embedded therein.
    Type: Grant
    Filed: January 16, 2014
    Date of Patent: August 25, 2015
    Assignee: Colorado State University Research Foundation
    Inventors: Il-Gyo Koo, Jin Hoon Cho, Myeong Yeol Choi, Cameron A. Moore, George J. Collins
  • Patent number: 9117817
    Abstract: Illustrative embodiments of semiconductor devices including a polar insulation layer capped by a non-polar insulation layer, and methods of fabrication of such semiconductor devices, are disclosed. In at least one illustrative embodiment, a semiconductor device may comprise a semiconductor substrate, a polar insulation layer disposed on the semiconductor substrate and comprising a Group V element configured to increase a carrier mobility in at least a portion of the semiconductor substrate, and a non-polar insulation layer disposed above the polar insulation layer.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: August 25, 2015
    Assignees: Auburn University, Rutgers, The State University of New Jersey
    Inventors: John R. Williams, Ayayi C. Ahyi, Tamara F. Isaacs-Smith, Yogesh K. Sharma, Leonard C. Feldman
  • Patent number: 9119294
    Abstract: A composite material for electromagnetic interference shielding is provided. The composite material comprises a stack including at least two electrically conductive nanoscale fiber films, which are spaced apart from one another by at least one insulating gap positioned between the at least two nanoscale fiber films. The stack is effective to provide a substantial multiple internal reflection effect. An electromagnetic interference shielded apparatus and a method for shielding an electrical circuit from electromagnetic interference is provided.
    Type: Grant
    Filed: August 26, 2013
    Date of Patent: August 25, 2015
    Assignee: Florida State University Research Foundation
    Inventors: Zhiyong Liang, Ben Wang, Chun Zhang, Jin Gyu Park
  • Patent number: 9115213
    Abstract: The present invention provides peptides (including analogs and derivatives thereof) corresponding to residues 96-110 and 35-47 of ras-p21, which peptides have attached thereto a membrane-penetrating leader sequence. The subject peptides, analogs and derivatives thereof are useful in treatment of cancers and have been shown to induce phenotypic reversion of pancreatic cancer cells to non-cancerous cells. Pharmaceutical compositions comprising one or more subject peptides are also provided by the present invention. The present invention further provides replication incompetent Adenovirus (AdV) vectors comprising a promoter sequence and a nucleotide sequence encoding a subject peptide. Methods of treating cancer by administering one or more subject peptides, pharmaceutical compositions, and/or AdV vectors are also provided.
    Type: Grant
    Filed: November 15, 2012
    Date of Patent: August 25, 2015
    Assignee: The Research Foundation of State University of New York
    Inventors: Matthew Pincus, Josef Michl
  • Patent number: 9118006
    Abstract: A variable resistance memory device that includes a first electrode, a second electrode, and a first chalcogenide material layer between the first and second electrodes, the chalcogenide layer including carbon incorporated into germanium selenide chalcogenide glass. The variable resistance memory device may include a second chalcogenide material layer between the first chalcogenide material layer and the second electrode. The variable resistance memory device may include a first metallic layer between the second chalcogenide material layer and the second electrode. The variable resistance memory device may include a third chalcogenide material layer between the first metallic layer and the second electrode. The variable resistance memory device may include a fourth chalcogenide material layer between the first chalcogenide material layer and the first electrode. The first chalcogenide layer may be formed by co-sputtering carbon with Ge40Se60.
    Type: Grant
    Filed: August 12, 2014
    Date of Patent: August 25, 2015
    Assignee: Boise State University
    Inventor: Kristy A. Campbell
  • Patent number: 9114576
    Abstract: The present invention provides a process for forming a composite material. The present invention further provides methods of improving the fiber volume fraction and/or the dimensional thickness of a composite panel.
    Type: Grant
    Filed: January 28, 2009
    Date of Patent: August 25, 2015
    Assignee: North Carolina Agricultural and Technical State University
    Inventors: Ronnie L. Bolick, Ajit D. Kelkar
  • Publication number: 20150232475
    Abstract: The invention provides novel nicotinic acetylcholine receptor agonists, for example, phantasmidine and derivatives thereof, for example a compound of formula I. Also disclosed are methods of treating disorders responsive to nicotinic acetylcholine receptor agonists such as Alzheimer's disease, schizophrenia, Myasthenia Gravis, Tourette's syndrome, Parkinson's disease, epilepsy, pain, and cognitive dysfunction by treatment with the nicotinic acetylcholine receptor agonists.
    Type: Application
    Filed: April 24, 2015
    Publication date: August 20, 2015
    Applicants: Indiana State University, The United States of America, as Represented by the Secretary, Department of Health and Human Serv
    Inventors: Richard W. Fitch, Thomas F. Spande, H. Martin Garraffo, Herman J.C. Yeh, John W. Daly
  • Publication number: 20150232576
    Abstract: Endothelial nitric oxide synthase (eNOS) activity was modulated by contact with an effective amount of a mitogen-activated protein (MAP) kinase, resulting in phosphorylation of S602, T46, and/or S58. Kinetics and stoichiometry are disclosed. The contact strongly reduced nitric oxide (NO) synthesis, and inhibited the cytochrome c reductase activity of eNOS reductase domains. Three sites of phosphorylation were determined that matched the serine-proline (SP) and threonine-proline (TP) motifs of typical MAP kinase phosphorylation sites.
    Type: Application
    Filed: March 30, 2015
    Publication date: August 20, 2015
    Applicant: Kennesaw State University Research and Services Foundation, Inc.
    Inventors: John C. Salerno, Carol A. Chrestensen